Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claire M Edwards

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Blood|December 21, 2007
Increasing Wnt signaling in the bone marrow microenvironment inhibits the development of myeloma bone disease and reduces tumor burden in bone in vivoClaire M Edwards, James R Edwards, Seint T Lwin, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 31, 2019
Myeloma Cells Down-Regulate Adiponectin in Bone Marrow Adipocytes Via TNF-AlphaEmma V Morris, Karla J Suchacki, Joseph Hocking, et al.
Science Advances|February 25, 2022
Metabolic profiling of prostate cancer in skeletal microenvironments identifies G6PD as a key mediator of growth and survivalJessica Whitburn, Srinivasa R Rao, Emma V Morris, et al.
Scientific Reports|October 4, 2019
Multiple myeloma increases nerve growth factor and other pain-related markers through interactions with the bone microenvironmentSam W Z Olechnowicz, Megan M Weivoda, Seint T Lwin, et al.
International Journal of Cancer|January 19, 2007
Apomine, an inhibitor of HMG-CoA-reductase, promotes apoptosis of myeloma cells in vitro and is associated with a modulation of myeloma in vivoClaire M Edwards, Gabrielle Mueller, Anke J Roelofs, et al.
Cancers|January 8, 2023
Prospective Assessment of Tumour Burden and Bone Disease in Plasma Cell Dyscrasias Using DW-MRI and Exploratory Bone BiomarkersGaurav Agarwal, Guido Nador, Sherin Varghese, et al.
Nature Reviews. Urology|January 16, 2026
Circulating tumour cells as a window into lethality in prostate cancerSophia M Abusamra, Thineskrishna Anbarasan, Daniele T Cotton, et al.
Nature Communications|October 6, 2019
Transcriptomic profiling of the myeloma bone-lining niche reveals BMP signalling inhibition to improve bone diseaseSarah Gooding, Sam W Z Olechnowicz, Emma V Morris, et al.
Nature Communications|December 22, 2022
Modulating glycosphingolipid metabolism and autophagy improves outcomes in pre-clinical models of myeloma bone diseaseHoufu Leng, Hanlin Zhang, Linsen Li, et al.
The EMBO Journal|February 16, 2023
Adipocyte autophagy limits gut inflammation by controlling oxylipin and IL-10Felix Clemens Richter, Matthias Friedrich, Nadja Kampschulte, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Blood|December 21, 2007
Increasing Wnt signaling in the bone marrow microenvironment inhibits the development of myeloma bone disease and reduces tumor burden in bone in vivoClaire M Edwards, James R Edwards, Seint T Lwin, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 31, 2019
Myeloma Cells Down-Regulate Adiponectin in Bone Marrow Adipocytes Via TNF-AlphaEmma V Morris, Karla J Suchacki, Joseph Hocking, et al.
Science Advances|February 25, 2022
Metabolic profiling of prostate cancer in skeletal microenvironments identifies G6PD as a key mediator of growth and survivalJessica Whitburn, Srinivasa R Rao, Emma V Morris, et al.
Scientific Reports|October 4, 2019
Multiple myeloma increases nerve growth factor and other pain-related markers through interactions with the bone microenvironmentSam W Z Olechnowicz, Megan M Weivoda, Seint T Lwin, et al.
International Journal of Cancer|January 19, 2007
Apomine, an inhibitor of HMG-CoA-reductase, promotes apoptosis of myeloma cells in vitro and is associated with a modulation of myeloma in vivoClaire M Edwards, Gabrielle Mueller, Anke J Roelofs, et al.
Cancers|January 8, 2023
Prospective Assessment of Tumour Burden and Bone Disease in Plasma Cell Dyscrasias Using DW-MRI and Exploratory Bone BiomarkersGaurav Agarwal, Guido Nador, Sherin Varghese, et al.
Nature Reviews. Urology|January 16, 2026
Circulating tumour cells as a window into lethality in prostate cancerSophia M Abusamra, Thineskrishna Anbarasan, Daniele T Cotton, et al.
Nature Communications|October 6, 2019
Transcriptomic profiling of the myeloma bone-lining niche reveals BMP signalling inhibition to improve bone diseaseSarah Gooding, Sam W Z Olechnowicz, Emma V Morris, et al.
Nature Communications|December 22, 2022
Modulating glycosphingolipid metabolism and autophagy improves outcomes in pre-clinical models of myeloma bone diseaseHoufu Leng, Hanlin Zhang, Linsen Li, et al.
The EMBO Journal|February 16, 2023
Adipocyte autophagy limits gut inflammation by controlling oxylipin and IL-10Felix Clemens Richter, Matthias Friedrich, Nadja Kampschulte, et al.
Pageof 6